跳至主要内容
临床试验/JPRN-UMIN000023862
JPRN-UMIN000023862已完成未知

A Comparative study of efficacy and safety of Tapcom combination ophthalmic solution and Xalacom combination eye drops. - A Comparative study of efficacy and safety of Tapcom combination ophthalmic solution and Xalacom combination eye drops.

Santen Pharmaceutical Co., Ltd.0 个研究点目标入组 150 人开始时间: 2016年9月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • There is risk of visual field disorder drastically progressing during the study period. Has retinal which may aggravate during the study period. Has active extraocular disease, inflammation or infection of the eye or eyelids Has corneal abnormalities or other diseases which would prohibit accurate IOP measurement by Goldmann applanation tonometer Has undergone LASIK surgery Patients who are contraindicated to beta blockers (those who with bronchial asthma or insufficiently controlled heart failure) Patients with allergy to the ingredients used in the present study Female who is pregnant, lactating, or may possibly be pregnant , wishes to become pregnant during the study period, or cannot use appropriate contraceptive method.

研究者

相似试验